Fellowship · Houston, TX
Sponsored by University of Texas M D Anderson Cancer Center
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 560 citations · Sharon Giordano
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 759 citations · Sharon Giordano
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
The New England journal of medicine · 2023 · 703 citations · Bradley Monk, Larry Copeland
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Marta Crispens, Jean Siedel, Pamela Soliman
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
The New England journal of medicine · 2023 · 633 citations · Emily Hinchcliff
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
The New England journal of medicine · 2021 · 855 citations · Bradley Monk
Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics.
Cancer cell · 2025 · 196 citations · Amir Jazaeri
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.
Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 274 citations · Pedro Ramirez